$SVRE

SaverOne 2014 Ltd.

CIK:0001894693|SEC Filings

Statements of Comprehensive Loss - ILS (₪) ₪ in Thousands	12 Months Ended
Statements of Comprehensive Loss - ILS (₪) ₪ in Thousands	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Profit or loss [abstract]
Revenues	₪ 1,016	₪ 1,683	₪ 2,720
Cost of revenues	(713)	(1,069)	(1,968)
Inventory impairment loss	(377)
Gross (loss) profit	(74)	614	752
Research and development expenses, net	(18,898)	(19,397)	(22,861)
Selling and marketing expenses, net	(3,355)	(4,796)	(3,787)
General and administrative expenses	(8,405)	(9,673)	(8,327)
Operating loss	(30,732)	(33,252)	(34,223)
Financing expenses	(3,506)	(2,785)	(1,219)
Financing income	4,795	1,099	1,607
Financing income (expenses), net	1,289	(1,686)	388
Loss for the year	(29,443)	(34,938)	(33,835)
Comprehensive loss for the year	₪ (29,443)	₪ (34,938)	₪ (33,835)
Basic and diluted loss per share:
Basic loss per share (in New Shekels per share)	₪ (0.01)	₪ (0.3)	₪ (1.08)
Diluted loss per share (in New Shekels per share)	₪ (0.01)	₪ (0.3)	₪ (1.08)
Weighted average of number of shares used to calculate the basic loss per share (in Shares)	4,006,539,396	117,908,475	31,380,359
Weighted average of number of shares used to calculate the diluted loss per share (in Shares)	4,006,539,396	117,908,475	31,380,359

Statements of Cash Flows - ILS (₪)

12 Months Ended

Dec. 31, 2025

Dec. 31, 2024

Dec. 31, 2023

Cash flow from current operations

Comprehensive loss for the year

₪ (29,443,000)

₪ (34,938,000)

₪ (33,835,000)

Adjustments required to present cash flows from operating activities (Appendix A)

236,000

532,000

(1,185,000)

Net cash used in operating activities

(29,207,000)

(34,406,000)

(35,020,000)

Cash flows from investment activity

Change in deposits restricted as to withdrawal

(5,000)

Changes in short-term deposits

10,070,000

Purchase of property and equipment

(7,000)

(79,000)

(128,000)

Net cash provided by (used in) investment activity

(7,000)

(84,000)

9,942,000

Cash flows from financing activity

Net proceeds received from issuance of units including put options, first promissory note and ADSs as Commitment Shares in transaction of equity line granted

7,170,000

Proceeds received from issuance of ADSs resulted from partial exercise of Commitment Amount under equity line

21,962,000

16,277,000

9,259,000

Repayment of first promissory note

(754,000)

Net proceeds received from issuance of promissory notes

4,650,000

10,532,000

3,597,000

Repayment of government grants

(50,000)

(144,000)

Net proceeds received from issuance of ADSs through private placement transaction

Net proceeds received from issuance of ADSs and warrants as part of shelf prospectus through public offering transaction

4,900,000

4,222,000

3,685,000

Repayment of principal in respect of leasing

(469,000)

(352,000)

(467,000)

Proceeds from issuance of ADSs

1,076,000

Exercise of restricted share units into ordinary shares

^[1]

Net cash provided by financing activity

32,069,000

30,535,000

22,490,000

Change in balance of cash and cash equivalents

2,855,000

(3,955,000)

(2,588,000)

Exchange differences on cash and cash equivalents

(2,009,000)

141,000

460,000

Balance of cash and cash equivalents, beginning of year

13,298,000

17,112,000

19,240,000

Balance of cash and cash equivalents, end of year

14,144,000

13,298,000

17,112,000

Income and expenses not involving cash flows

Depreciation

82,000

98,000

Amortization of right for usage asset

380,000

320,000

425,000

Interest expense in respect of leasing

67,000

95,000

22,000

Share-based payment to service providers as part of shelf prospectus through public offering transaction

124,000

Share-based payment to employees and service providers

175,000

598,000

978,000

Revaluation of derivative warrant liability and related expenses

(3,176,000)

(274,000)

(877,000)

Recognition of discount, interest and exchange differences expenses related to promissory notes

468,000

1,246,000

526,000

Finance expenses incurred from partial exercise of Commitment Amount under equity line

101,000

1,318,000

531,000

Exchange differences on cash and cash equivalent and restricted deposits

2,009,000

(141,000)

(470,000)

Changes in liability in respect of government grants

(735,000)

(224,000)

74,000

Income and expenses not involving cash flows total

(505,000)

3,036,000

1,307,000

Changes in asset and liability items

Decrease (increase) in other current assets

223,000

(177,000)

(493,000)

Decrease (increase) in trade receivables

787,000

(320,000)

(1,008,000)

Decrease (increase) in inventory

1,200,000

(479,000)

(2,508,000)

Decrease in trade payables

(1,220,000)

(2,477,000)

2,347,000

Increase (decrease) in other current liabilities

(249,000)

949,000

(830,000)

Total

741,000

(2,504,000)

(2,492,000)

Adjustments required to present cash flows from operating activities (Appendix A)

236,000

532,000

(1,185,000)

Appendix B - Non-cash investment and financing activities

Recognition of right for usage asset against a leasing liability

1,129,000

Repayment of promissory notes (principal and interest) through issuance of ADSs resulted from partial exercise of Commitment Amount under equity line

6,970,000

12,581,000

3,313,000

Appendix C - Additional information pertaining to cash flows

Interest received

₪ 426,000

₪ 404,000

₪ 271,000

[1]	Representing amount lower than NIS 1.

Statements of Financial Position - ILS (₪) ₪ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	₪ 14,144	₪ 13,298
Trade receivables, net	1,186	1,621
Other current assets	387	1,686
Inventory	3,813	5,013
Total current assets	19,530	21,618
Non-current assets
Trade receivables, net	452	804
Property and equipment, net	154	229
Restricted deposits	216	216
Right of usage asset, net	571	951
Total non-current assets	1,393	2,200
Total assets	20,923	23,818
Current liabilities
Current maturities of leasing liability	469	469
Trade payables	606	1,826
Other current liabilities	2,742	2,991
Liability in respect of government grants	62	239
Promissory notes, net	4,484	6,336
Total current liabilities	8,363	11,861
Non-current liabilities
Leasing liability, net current	204	606
Liability in respect of government grants	113	721
Total non-current liabilities	317	1,327
Commitments
Shareholders’ equity
Share capital and premium	200,886	169,949
Capital reserve in respect of share-based payment	11,348	11,229
Accumulated deficit	(199,991)	(170,548)
Total shareholders’ equity	12,243	10,630
Total liabilities and shareholders’ equity	₪ 20,923	₪ 23,818